Barinthus Biotherapeutics plc (NASDAQ: BRNS)
$1.0250
+0.0775 ( +4.37% ) 35.9K
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
Market Data
Open
$1.0250
Previous close
$0.9475
Volume
35.9K
Market cap
$41.03M
Day range
$0.9350 - $1.0380
52 week range
$0.8008 - $4.1591
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 17 | Aug 08, 2024 |
| 10-q | Quarterly Reports | 75 | Aug 08, 2024 |
| 3 | Insider transactions | 2 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 8-k | 8K-related | 14 | Jun 12, 2024 |
| 8-k | 8K-related | 57 | Jun 06, 2024 |
| 8-k | 8K-related | 14 | May 15, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |